| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
Departments of 1 Surgery and Biochemistry and Molecular Biology and 2 Pathology, Norris Comprehensive Cancer Center; 3 Department of Pathology and Laboratory Medicine and 4 Saban Research Institute, Children's Hospital Los Angeles; 5 PET Imaging Science Center, Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California
Requests for reprints: Peter W. Laird, University of Southern California/Norris Comprehensive Cancer Center, Room 6418, 1441 Eastlake Avenue, Los Angeles, CA 90089-9176. Phone: 323-865-0650; Fax: 323-865-0158; E-mail: plaird{at}usc.edu.
Colorectal cancer, one of the most common human malignancies in the Western world, is often subdivided based on tumor location in either the distal or proximal colon. Several mouse models have been developed to study human colorectal cancer, but few display this clear distinction between the two colonic locations. By crossing ApcMin/+ and Smad3 mutant mice, we showed that combined activation of the Wnt pathway and attenuation of the transforming growth factor-ß (TGF-ß) pathway causes high multiplicity and rapid onset of invasive tumorigenesis almost exclusively in the distal colon, closely mimicking the familial adenomatous polyposis (FAP) disease and consisting with distinct colorectal cancer etiologies based on tumor location. Transcriptional profiling revealed higher expression of several TGF-ß activators in the normal distal mucosa than in proximal mucosa, suggesting a stronger reliance on TGF-ß-mediated growth control in the distal than in the proximal colon. ApcMin/+Smad3/ mice provide an alternative model to ApcMin/+ mice to study FAP and distal sporadic colorectal cancer. This model will be useful in dissecting mechanistic and etiologic differences between proximal and distal colonic cancer, whereas the confinement of tumorigenesis to the distal colon offers unique advantages in monitoring tumor progression by in vivo imaging. (Cancer Res 2006; 66(17): 8430-8)
This article has been cited by other articles:
![]() |
Q. Zeng, S. Phukan, Y. Xu, M. Sadim, D. S. Rosman, M. Pennison, J. Liao, G.-Y. Yang, C.-C. Huang, L. Valle, et al. Tgfbr1 Haploinsufficiency Is a Potent Modifier of Colorectal Cancer Development Cancer Res., January 15, 2009; 69(2): 678 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhao, G. Aguilar, S. Palencia, E. Newton, and A. Abo rNAPc2 Inhibits Colorectal Cancer in Mice through Tissue Factor Clin. Cancer Res., January 1, 2009; 15(1): 208 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yang, N. V. Popova, W. C. Yang, I. Lozonschi, S. Tadesse, S. Kent, L. Bancroft, I. Matise, R. T. Cormier, S. J. Scherer, et al. Interaction of Muc2 and Apc on Wnt Signaling and in Intestinal Tumorigenesis: Potential Role of Chronic Inflammation Cancer Res., September 15, 2008; 68(18): 7313 - 7322. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Valle, T. Serena-Acedo, S. Liyanarachchi, H. Hampel, I. Comeras, Z. Li, Q. Zeng, H.-T. Zhang, M. J. Pennison, M. Sadim, et al. Germline Allele-Specific Expression of TGFBR1 Confers an Increased Risk of Colorectal Cancer Science, September 5, 2008; 321(5894): 1361 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu and B. Pasche TGF-{beta} signaling alterations and susceptibility to colorectal cancer Hum. Mol. Genet., April 15, 2007; 16(R1): R14 - R20. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Deane, H. C. Manning, A. C. Foutch, M. K. Washington, B. A. Aronow, D. J. Bornhop, and R. J. Coffey Targeted Imaging of Colonic Tumors in Smad3-/- Mice Discriminates Cancer and Inflammation Mol. Cancer Res., April 1, 2007; 5(4): 341 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Amos-Landgraf, L. N. Kwong, C. M. Kendziorski, M. Reichelderfer, J. Torrealba, J. Weichert, J. D. Haag, K.-S. Chen, J. L. Waller, M. N. Gould, et al. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer PNAS, March 6, 2007; 104(10): 4036 - 4041. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |